MicroRNAs regulate the immunometabolic response to viral infection in the liver

Nature Chemical Biology

Volumn 11, Issue 12, 2015, Pages 988-993

  Singaravelu, Ragunath ^a,b   O'Hara, Shifawn ^b   Jones, Daniel M ^c   Chen, Ran ^d   Taylor, Nathan G ^c   Srinivasan, Prashanth ^a,b   Quan, Curtis ^a,b   Roy, Dominic G ^e   Steenbergen, Rineke H ^d   Kumar, Anil ^f   Lyn, Rodney K ^a,b   Özcelik, Dennis ^a,b   Rouleau, Yanouchka ^b   Nguyen, My Anh ^a,g   Rayner, Katey J ^a,g   Hobman, Tom C ^f   Tyrrell, David Lorne ^d   Russell, Rodney S ^c   Pezacki, John Paul ^a,b  

^a UNIVERSITY OF OTTAWA   (Canada)

^b NATIONAL RESEARCH COUNCIL CANADA   (Canada)

^c MEMORIAL UNIVERSITY OF NEWFOUNDLAND   (Canada)

^d UNIVERSITY OF ALBERTA   (Canada)

^e OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

^f UNIVERSITY OF ALBERTA   (Canada)

^g UNIVERSITY OF OTTAWA HEART INSTITUTE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

25 HYDROXYCHOLESTEROL; MICRORNA; MICRORNA 130B; MICRORNA 185; UNCLASSIFIED DRUG; 25-HYDROXYCHOLESTEROL; ANTIVIRUS AGENT; CHOLESTEROL DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIVIRAL ACTIVITY; ARTICLE; CONTROLLED STUDY; DENDRITIC CELL; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENE IDENTIFICATION; GENE REPRESSION; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOREGULATION; LIPID METABOLISM; LIPID STORAGE; LIVER METABOLISM; MACROPHAGE; METABOLIC REGULATION; MICROENVIRONMENT; MOUSE; NONHUMAN; PRIORITY JOURNAL; VIRUS IMMUNITY; CELL LINE; CONFORMATION; DRUG EFFECTS; GENETICS; HEPACIVIRUS; IMMUNOLOGY; LIVER; METABOLISM; VIROLOGY;

ANTIVIRAL AGENTS; CELL LINE; HEPACIVIRUS; HEPATITIS C; HUMANS; HYDROXYCHOLESTEROLS; LIVER; MICRORNAS; MOLECULAR CONFORMATION;

EID: 84947287935     PISSN: 15524450     EISSN: 15524469     Source Type: Journal    
DOI: 10.1038/nchembio.1940     Document Type: Article

References (59)

1. Teissier, E. & Pécheur, E.I. Lipids as modulators of membrane fusion mediated by viral fusion proteins. Eur. Biophys. J. 36, 887-899 (2007).
2. Chukkapalli, V., Heaton, N.S. & Randall, G. Lipids at the interface of virus-host Interactions. Curr. Opin. Microbiol. 15, 512-518 (2012).
3. Miller, S. & Krijnse-Locker, J. Modification of intracellular membrane structures for virus replication. Nat. Rev. Microbiol. 6, 363-374 (2008).
4. Saka, H.A. & Valdivia, R. Emerging roles for lipid droplets in immunity and host-pathogen interactions. Annu. Rev. Cell Dev. Biol. 28, 411-437 (2012).
5. Schoggins, J.W. & Randall, G. Lipids in innate antiviral defense. Cell Host Microbe 14, 379-385 (2013).
6. Blanc, M. et al. The transcription factor STAT-1 couples macrophage synthesis of 25-hydroxycholesterol to the interferon antiviral response. Immunity 38, 106-118 (2013).
7. Liu, S.Y. et al. Interferon-inducible cholesterol-25-hydroxylase broadly inhibits viral entry by production of 25-hydroxycholesterol. Immunity 38, 92-105 (2013).
8. Pezacki, J.P. et al. Transcriptional profiling of the effects of 25-hydroxycholesterol on human hepatocyte metabolism and the antiviral state it conveys against the hepatitis C virus. BMC Chem. Biol. 9, 2 (2009).
9. Park, K. & Scott, A.L. Cholesterol 25-hydroxylase production by dendritic cells and macrophages is regulated by type I interferons. J. Leukoc. Biol. 88, 1081-1087 (2010).
10. Carthew, R.W. & Sontheimer, E.J. Origins and mechanisms of miRNAs and siRNAs. Cell 136, 642-655 (2009).
11. Friedman, R.C., Farh, K.K.H., Burge, C.B. & Bartel, D.P. Most mammalian mRNAs are conserved targets of microRNAs. Genome Res. 19, 92-105 (2009).
12. Rottiers, V. & Näär, A.M. MicroRNAs in metabolism and metabolic disorders. Nat. Rev. Mol. Cell Biol. 13, 239-250 (2012).
13. Wu, J.M., Skill, N.J. & Maluccio, M.A. Evidence of aberrant lipid metabolism in hepatitis C and hepatocellular carcinoma. HPB (Oxford) 12, 625-636 (2010).
14. Adams, C.M. et al. Cholesterol and 25-hydroxycholesterol inhibit activation of SREBPs by different mechanisms, both involving SCAP and Insigs. J. Biol. Chem. 279, 52772-52780 (2004).
15. Radhakrishnan, A., Ikeda, Y., Kwon, H.J., Brown, M.S. & Goldstein, J.L. Sterol-regulated transport of SREBPs from endoplasmic reticulum to Golgi: oxysterols block transport by binding to Insig. Proc. Natl. Acad. Sci. USA 104, 6511-6518 (2007).
16. Janowski, B.A., Willy, P.J., Devi, T.R., Falck, J.R. & Mangelsdorf, D.J. An oxysterol signalling pathway mediated by the nuclear receptor LXRα. Nature 383, 728-731 (1996).
17. Goldstein, J.L., DeBose-Boyd, R.A. & Brown, M.S. Protein sensors for membrane sterols. Cell 124, 35-46 (2006).
18. Su, A.I. et al. Genomic analysis of the host response to hepatitis C virus infection. Proc. Natl. Acad. Sci. USA 99, 15669-15674 (2002).
19. Zeng, J. et al. Liver X receptors agonists impede hepatitis C virus infection in an Idol-dependent manner. Antiviral Res. 95, 245-256 (2012).
20. Russell, R.S. et al. Advantages of a single-cycle production assay to study cell culture-adaptive mutations of hepatitis C virus. Proc. Natl. Acad. Sci. USA 105, 4370-4375 (2008).
21. Vlachos, I.S. et al. DIANA miRPath v.2.0: investigating the combinatorial effect of microRNAs in pathways. Nucleic Acids Res. 40, W498-W504 (2012).
22. Luna, J.M. et al. Hepatitis C virus RNA functionally sequesters miR-122. Cell 160, 1099-1110 (2015).
23. Qadir, X.V., Han, C., Lu, D., Zhang, J. & Wu, T. miR-185 inhibits hepatocellular carcinoma growth by targeting the DNMT1/PTEN/Akt pathway. Am. J. Pathol. 184, 2355-2364 (2014).
24. Xiao, F. et al. A novel function of microRNA 130a-3p in hepatic insulin sensitivity and liver steatosis. Diabetes 63, 2631-2642 (2014).
25. Steenbergen, R.H.G. et al. Human serum leads to differentiation of human hepatoma cells, restoration of very-low-density lipoprotein secretion, and a 1000-fold increase in HCV Japanese fulminant hepatitis type 1 titers. Hepatology 58, 1907-1917 (2013).
26. Alvisi, G., Madan, V. & Bartenschlager, R. Hepatitis C virus and host cell lipids: an intimate connection. RNA Biol. 8, 258-269 (2011).
27. Pezacki, J.P., Singaravelu, R. & Lyn, R.K. Host-virus interactions during hepatitis C virus infection: a complex and dynamic molecular biosystem. Mol. Biosyst. 6, 1131-1142 (2010).
28. García-Mediavilla, M.V. et al. Liver X receptor α-mediated regulation of lipogenesis by core and NS5A proteins contributes to HCV-induced liver steatosis and HCV replication. Lab. Invest. 92, 1191-1202 (2012).
29. Waris, G., Felmlee, D.J., Negro, F. & Siddiqui, A. Hepatitis C virus induces proteolytic cleavage of sterol regulatory element binding proteins and stimulates their phosphorylation via oxidative stress. J. Virol. 81, 8122-8130 (2007).
30. Pezacki, J.P. et al. Chemical contrast for imaging living systems: molecular vibrations drive CARS microscopy. Nat. Chem. Biol. 7, 137-145 (2011).
31. Yang, M. et al. Identification of miR-185 as a regulator of de novo cholesterol biosynthesis and low density lipoprotein uptake. J. Lipid Res. 55, 226-238 (2014).
32. Wang, L. et al. MicroRNAs 185, 96, and 223 repress selective high-density lipoprotein cholesterol uptake through posttranscriptional inhibition. Mol. Cell. Biol. 33, 1956-1964 (2013).
33. Pan, S., Yang, X., Jia, Y., Li, R. & Zhao, R. Microvesicle-shuttled miR-130b reduces Fat deposition in recipient primary cultured porcine adipocytes by inhibiting PPAR-γ expression. J. Cell. Physiol. 229, 631-639 (2014).
34. Hsu, P.W.C., Lin, L.Z., Hsu, S.D., Hsu, J.B.K. & Huang, H.-D. ViTa: prediction of host microRNAs targets on viruses. Nucleic Acids Res. 35, D381-D385 (2007).
35. Lyn, R.K. et al. Stearoyl-CoA desaturase inhibition blocks formation of hepatitis C virus-induced specialized membranes. Sci. Rep. 4, 4549 (2014).
36. Régeard, M., Trotard, M., Lepère, C., Gripon, P. & Le Seyec, J. Entry of pseudotyped hepatitis C virus into primary human hepatocytes depends on the scavenger class B type I receptor. J. Viral Hepat. 15, 865-870 (2008).
37. Catanese, M.T. et al. Different requirements for scavenger receptor class B type I in hepatitis C virus cell-free versus cell-to-cell transmission. J. Virol. 87, 8282-8293 (2013).
38. Li, Q., Pene, V., Krishnamurthy, S., Cha, H. & Liang, T.J. Hepatitis C virus infection activates an innate pathway involving IKK-α in lipogenesis and viral assembly. Nat. Med. 19, 722-729 (2013).
39. Syed, G.H. et al. Hepatitis C Virus stimulates low-density lipoprotein receptor expression to facilitate viral propagation. J. Virol. 88, 2519-2529 (2014).
40. Monazahian, M. et al. Low density lipoprotein receptor as a candidate receptor for hepatitis C virus. J. Med. Virol. 57, 223-229 (1999).
41. Takeuchi, K. & Reue, K. Biochemistry, physiology, and genetics of GPAT, AGPAT, and lipin enzymes in triglyceride synthesis. Am. J. Physiol. Endocrinol. Metab. 296, E1195-E1209 (2009).
42. Mercer, D.F. et al. Hepatitis C virus replication in mice with chimeric human livers. Nat. Med. 7, 927-933 (2001).
43. Singaravelu, R. et al. Hepatitis C virus induced up-regulation of microRNA-27: A novel mechanism for hepatic steatosis. Hepatology 59, 98-108 (2014).
44. Paul, D., Hoppe, S., Saher, G., Krijnse-Locker, J. & Bartenschlager, R. Morphological and biochemical characterization of the membranous hepatitis C virus replication compartment. J. Virol. 87, 10612-10627 (2013).
45. Sagan, S.M. et al. The influence of cholesterol and lipid metabolism on host cell structure and hepatitis C virus replication. Biochem. Cell Biol. 84, 67-79 (2006).
46. Li, S. et al. MicroRNA-130a inhibits HCV replication by restoring the innate immune response. J. Viral Hepat. 21, 121-128 (2014).
47. Lee, W.M. & Ahlquist, P. Membrane synthesis, specific lipid requirements, and localized lipid composition changes associated with a positive-strand RNA Virus RNA replication protein. J. Virol. 77, 12819-12828 (2003).
48. Civra, A. et al. Inhibition of pathogenic non-enveloped viruses by 25-hydroxycholesterol and 27-hydroxycholesterol. Sci. Rep. 4, 7487 (2014).
49. Pedersen, I.M. et al. Interferon modulation of cellular microRNAs as an antiviral mechanism. Nature 449, 919-922 (2007).
50. Bassendine, M.F., Sheridan, D.A., Bridge, S.H., Felmlee, D.J. & Neely, R.D.G. Lipids and HCV. Semin. Immunopathol. 35, 87-100 (2013).
51. Blight, K.J., Kolykhalov, A.A. & Rice, C.M. Efficient initiation of HCV RNA replication in cell culture. Science 290, 1972-1974 (2000).
52. Gong, E.Y., Fischl, W. & Bartenschlager, R. in Antiviral Methods and Protocols Vol. 1030, 205-219 (Humana Press).
53. Kumar, A. et al. Nuclear localization of Dengue virus nonstructural protein 5 Does Not strictly correlate with efficient viral RNA replication and inhibition of type I interferon signaling. J. Virol. 87, 4545-4557 (2013).
54. Stojdl, D.F. et al. VSV strains with defects in their ability to shutdown innate immunity are potent systemic anti-cancer agents. Cancer Cell 4, 263-275 (2003).
55. Liu, Q.Y. et al. Identification of microRNAs involved in Alzheimer's progression using a rabbit model of the disease. Am. J. Neurodegener. Dis. 3, 33-44 (2014).
56. Chen, J., Bardes, E.E., Aronow, B.J. & Jegga, A.G. ToppGene Suite for gene list enrichment analysis and candidate gene prioritization. Nucleic Acids Res. 37, W305-W311 (2009).
57. Dyer, B.W., Ferrer, F.A., Klinedinst, D.K. & Rodriguez, R. A noncommercial dual luciferase enzyme assay system for reporter gene analysis. Anal. Biochem. 282, 158-161 (2000).
58. Folch, J., Lees, M. & Stanley, G.H.S. A simple method for the isolation and purification of total lipids from animal tissues. J. Biol. Chem. 226, 497-509 (1957).
59. Graeve, M. & Janssen, D. Improved separation and quantification of neutral and polar lipid classes by HPLC-ELSD using a monolithic silica phase: application to exceptional marine lipids. J. Chromatogr. B 877, 1815-1819 (2009).